胆管癌中慢性肝病的患病率:一项Meta分析
该单臂Meta分析检索MEDLINE和EMBASE至2024年8月10日,纳入109项研究、118,068例胆管癌患者,其中16,771例合并慢性肝病。汇总患病率显示慢性肝病为25.23%(95%CI 20.82%-30.23%;I²=99.0%),肝硬化为10.21%(7.75%-13.35%;I²=98.6%);慢性肝病与肝内胆管癌的关联强于肝外胆管癌(RR 2.46;95%CI 2.37-2.55;P<.0001),但原发性硬化性胆管炎与肝外胆管癌相关(RR 0.49;95%CI 0.43-0.57;P<.0001)。
要点
- 胆管癌患者中约1/4合并慢性肝病,约1/10合并肝硬化。
- 慢性肝病与肝内胆管癌的关联强于肝外胆管癌(RR 2.46)。
- 原发性硬化性胆管炎与肝外胆管癌相关(RR 0.49)。
核心结论
- 约1/4的胆管癌患者合并慢性肝病,约1/10合并肝硬化。
研究设计与样本
- 单臂Meta分析,检索MEDLINE和EMBASE自建库至2024年8月10日的英文文献,纳入包含胆管癌伴或不伴慢性肝病数据的文章。
- 共纳入118,068例诊断为胆管癌的个体,其中16,771例合并慢性肝病;汇总分析基于109项研究。
主要发现
- 109项研究的汇总分析显示,慢性肝病患病率为25.23%(95%CI 20.82%-30.23%;I²=99.0%)。
- 胆管癌患者中肝硬化患病率为10.21%(95%CI 7.75%-13.35%;I²=98.6%)。
- 慢性肝病与肝内胆管癌的关联强于肝外胆管癌(相对风险2.46;95%CI 2.37-2.55;P<.0001)。
- 除原发性硬化性胆管炎外,所有病因的肝病均显示上述与肝内胆管癌的关联;原发性硬化性胆管炎与肝外胆管癌相关(相对风险0.49;95%CI 0.43-0.57;P<.0001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Chronic liver disease is a known risk factor for cholangiocarcinoma (CCA), but the proportion of people with CCA who have concurrent chronic liver disease is unclear. We aimed to evaluate the prevalence of chronic liver diseases in people with CCA. METHODS: In this single-arm meta-analysis, we searched MEDLINE and EMBASE from inception to August 10, 2024, for articles in English containing data for CCA with and without chronic liver diseases. Data were pooled to obtain the prevalence of different chronic liver diseases, with further stratification by geographical location and tumor location. RESULTS: In total, 118,068 individuals diagnosed with CCA were included, of whom 16,771 had chronic liver diseases. A pooled analysis of 109 studies determined that the prevalence of chronic liver disease was 25.23% (95% confidence interval [CI], 20.82%-30.23%; I2 = 99.0%), and 10.21% (7.75%-13.35%; I2 = 98.6%) of CCA patients had cirrhosis. Chronic liver diseases were associated more with intrahepatic CCAs, compared with extrahepatic CCAs (relative risk, 2.46; 95% CI, 2.37-2.55; P < .0001). This was observed across all etiologies of liver disease, except for primary sclerosing cholangitis, which was associated with extrahepatic CCAs (relative risk, 0.49; 95% CI, 0.43-0.57; P < .0001). CONCLUSIONS: Around 1 in 4 people with CCA have chronic liver diseases, and 1 in 10 have cirrhosis.
引用
- Tham EKJ, Lim RY, Koh B, et al. Prevalence of Chronic Liver Disease in Cholangiocarcinoma: A Meta-Analysis. Clin Gastroenterol Hepatol. 2024. PMID: 39461458. doi:10.1016/j.cgh.2024.09.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。